36
Participants
Start Date
August 5, 2024
Primary Completion Date
October 15, 2025
Study Completion Date
October 15, 2025
AZD4604
Janus kinase 1 (JAK1) inhibitor
Placebo to AZD4604
Placebo to AZD4604
Research Site, København NV
Research Site, Barcelona
Research Site, Großhansdorf
Research Site, Santander
Research Site, Frankfurt
Research Site, Calgary
Research Site, Vancouver
Research Site, Montreal
Research Site, Québec
Research Site, Palma de Mallorca
Research Site, Birmingham
Research Site, Glasgow
Research Site, Headington
Research Site, Leicester
Research Site, Liverpool
Research Site, London
Research Site, Manchester
Research Site, Southampton
Lead Sponsor
AstraZeneca
INDUSTRY